Viewing StudyNCT00323362



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00323362
Status: TERMINATED
Last Update Posted: 2014-05-22
First Post: 2006-03-07

Brief Title: Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Sponsor: Rutgers The State University of New Jersey
Organization: Rutgers The State University of New Jersey

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
stage IV non-small cell lung cancer View
recurrent non-small cell lung cancer View